William Blair & Company’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$667K Sell
4,852
-4,581
-49% -$630K ﹤0.01% 1003
2025
Q1
$1.7M Buy
9,433
+1,990
+27% +$359K 0.01% 754
2024
Q4
$1.17M Buy
7,443
+1,875
+34% +$294K ﹤0.01% 853
2024
Q3
$1.01M Buy
5,568
+2
+0% +$364 ﹤0.01% 902
2024
Q2
$1.02M Sell
5,566
-36
-0.6% -$6.61K ﹤0.01% 868
2024
Q1
$997K Sell
5,602
-550
-9% -$97.9K ﹤0.01% 869
2023
Q4
$763K Buy
6,152
+20
+0.3% +$2.48K ﹤0.01% 945
2023
Q3
$711K Sell
6,132
-885
-13% -$103K ﹤0.01% 945
2023
Q2
$824K Sell
7,017
-40
-0.6% -$4.7K ﹤0.01% 910
2023
Q1
$565K Buy
7,057
+100
+1% +$8.01K ﹤0.01% 1000
2022
Q4
$551K Buy
6,957
+580
+9% +$45.9K ﹤0.01% 1012
2022
Q3
$444K Buy
6,377
+1,285
+25% +$89.5K ﹤0.01% 1085
2022
Q2
$334K Buy
+5,092
New +$334K ﹤0.01% 1222
2022
Q1
Sell
-8,896
Closed -$622K 1958
2021
Q4
$622K Sell
8,896
-84,242
-90% -$5.89M ﹤0.01% 1131
2021
Q3
$4.86M Buy
93,138
+34,383
+59% +$1.8M 0.02% 463
2021
Q2
$4M Buy
58,755
+4,589
+8% +$312K 0.01% 511
2021
Q1
$4.17M Buy
54,166
+18,908
+54% +$1.46M 0.02% 495
2020
Q4
$2.12M Sell
35,258
-761
-2% -$45.7K 0.01% 635
2020
Q3
$1.55M Sell
36,019
-13,880
-28% -$598K 0.01% 649
2020
Q2
$2.07M Sell
49,899
-10,982
-18% -$455K 0.01% 547
2020
Q1
$2.63M Sell
60,881
-2,873
-5% -$124K 0.02% 458
2019
Q4
$3.53M Buy
63,754
+5,263
+9% +$291K 0.02% 476
2019
Q3
$2.03M Buy
58,491
+39,225
+204% +$1.36M 0.01% 568
2019
Q2
$776K Sell
19,266
-46,940
-71% -$1.89M ﹤0.01% 834
2019
Q1
$2.18M Buy
66,206
+44,426
+204% +$1.46M 0.01% 535
2018
Q4
$453K Buy
+21,780
New +$453K ﹤0.01% 937